Personalis to Announce Second Quarter 2024 Financial Results
Personalis (Nasdaq: PSNL), a leader in advanced genomics for cancer, has announced it will release its second quarter 2024 financial results on Wednesday, August 7, 2024. The company will host a conference call and webcast at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on the same day to discuss the results and recent highlights. Interested parties can access the call by dialing 800-717-1738 (domestic) or 646-307-1865 (international). The webinar can be accessed through the Events section of the company's website at investors.personalis.com. A replay of the webinar will be available shortly after the call and archived on the company's website.
Personalis (Nasdaq: PSNL), leader nella genomica avanzata per il cancro, ha annunciato che rilascerà i suoi risultati finanziari del secondo trimestre 2024 il mercoledì 7 agosto 2024. L'azienda ospiterà una conferenza telefonica e un webcast alle 14:00 ora del Pacifico / 17:00 ora dell'Est nello stesso giorno per discutere i risultati e i recenti punti salienti. Le parti interessate possono accedere alla chiamata componendo il numero 800-717-1738 (nazionale) o 646-307-1865 (internazionale). Il webinar può essere accessibile tramite la sezione Eventi del sito web dell'azienda all'indirizzo investors.personalis.com. Una registrazione del webinar sarà disponibile subito dopo la chiamata e archiviata sul sito web dell'azienda.
Personalis (Nasdaq: PSNL), líder en genómica avanzada para el cáncer, ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 el miércoles 7 de agosto de 2024. La compañía realizará una llamada de conferencia y un webcast a las 2:00 p.m. Hora del Pacífico / 5:00 p.m. Hora del Este el mismo día para discutir los resultados y los recientes puntos destacados. Las partes interesadas pueden acceder a la llamada marcando 800-717-1738 (nacional) o 646-307-1865 (internacional). El seminario web se podrá acceder a través de la sección de Eventos en el sitio web de la empresa en investors.personalis.com. Una repetición del seminario web estará disponible poco después de la llamada y se archivará en el sitio web de la compañía.
Personalis (Nasdaq: PSNL)는 암을 위한 고급 유전체학의 선두주자로서 2024년 2분기 재무 결과를 2024년 8월 7일 수요일에 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 2시 태평양 표준시 / 오후 5시 동부 표준시에 결과 및 최근 성과를 논의하기 위한 컨퍼런스 콜 및 웹캐스트를 개최할 예정입니다. 관심 있는 참가자는 800-717-1738 (국내) 또는 646-307-1865 (국제)로 전화를 걸어 참여할 수 있습니다. 웹 세미나는 회사 웹사이트의 이벤트 섹션을 통해 접근할 수 있으며, 투자자.personalis.com 에서 찾을 수 있습니다. 콜 후 곧 웹 세미나의 녹화본이 제공되며 회사 웹사이트에 보관될 것입니다.
Personalis (Nasdaq: PSNL), un leader dans le domaine de la génomique avancée pour le cancer, a annoncé qu'il publiera ses résultats financiers du deuxième trimestre 2024 le mercredi 7 août 2024. L'entreprise animera une conférence téléphonique et un webinaire le même jour à 14h00 heure du Pacifique / 17h00 heure de l'Est pour discuter des résultats et des points saillants récents. Les parties intéressées peuvent accéder à l'appel en composant le 800-717-1738 (domestique) ou le 646-307-1865 (international). Le webinaire peut être accessible via la section Événements du site web de l'entreprise à l'adresse investors.personalis.com. Un enregistrement du webinaire sera disponible peu après l'appel et archivé sur le site web de l'entreprise.
Personalis (Nasdaq: PSNL), ein führendes Unternehmen im Bereich fortschrittlicher Genomik für Krebs, hat angekündigt, dass es seine Finanzergebnisse für das zweite Quartal 2024 am Mittwoch, den 7. August 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 14:00 Uhr Pazifische Zeit / 17:00 Uhr Eastern Zeit eine Telefonkonferenz und ein Webcast durchführen, um die Ergebnisse und die jüngsten Höhepunkte zu erörtern. Interessierte können an dem Anruf teilnehmen, indem sie 800-717-1738 (inland) oder 646-307-1865 (international) wählen. Das Webinar kann über den Bereich Veranstaltungen auf der Unternehmenswebsite unter investors.personalis.com aufgerufen werden. Eine Wiederholung des Webinars wird kurz nach dem Anruf zur Verfügung stehen und auf der Unternehmenswebsite archiviert.
- None.
- None.
Interested parties may access the call by dialing 800-717-1738 for domestic callers or 646-307-1865 for international callers. The webinar of the call may be accessed by visiting the Events section of the company's website at investors.personalis.com. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on the company's website.
About Personalis, Inc.
At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest timepoints, enable the selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240724474751/en/
Investors:
Caroline Corner
investors@personalis.com
415-202-5678
Media:
pr@personalis.com
Source: Personalis, Inc.
FAQ
When will Personalis (PSNL) release its Q2 2024 financial results?
What time is the Personalis (PSNL) Q2 2024 earnings call scheduled for?
How can investors access the Personalis (PSNL) Q2 2024 earnings call?
Will there be a replay available for the Personalis (PSNL) Q2 2024 earnings call?
